ISPOR Europe 2025 Home
  • About
    • Registration Information
    • News Center
  • Program
    • Program
    • Plenary Sessions
    • Posters
    • Student Program
    • Learning Formats
    • Program Committee
    • Digital Conference Pass
  • Exhibits & Sponsorship
    • Sponsors
    • Media Partners
    • Exhibitor Directory
  • Photo Gallery
  • Award Winners
large-circle

ISPOR Europe 2025

9 - 12 November

  • Home
  • Events
  • Upcoming Conferences & Events
  • ISPOR Europe 2026
  • Program
  • Paper
  • Empirical Comparison of Subjective Well-Being and Health-Related Quality of Life Measures in Australian Adolescents

    Sep 22, 2025, 16:24 PM
  • Eliciting Preferences for Combination Vaccines Protecting Against Multiple Respiratory Viruses: A Cross-Sectional Discrete Choice Experiment of Adults Aged 50 in the US

    Sep 22, 2025, 16:24 PM
  • A Systematic Review of Economic Modeling Challenges and Proposed Solutions for Rare Disease Technologies: An HTAi RDIG Initiative

    Sep 22, 2025, 16:24 PM
  • Early Economic Modeling to Estimate Cost-Effectiveness and Value-Based Price of a Gene Therapy for Urofacial Syndrome

    Sep 22, 2025, 16:24 PM
  • Cost-Effectiveness Modeling of CAR-T Cell Therapies in Hematologic Malignancies: Insights From NICE and CDA-AMC Appraisals

    Sep 22, 2025, 16:24 PM
  • Cost-Effectiveness and Budget Impact of Gene Therapy for Eligible Patients With Sickle Cell Disease in the Netherlands

    Sep 22, 2025, 16:24 PM
  • Quality of Life and Utility Values Across the Alzheimer’s Disease Spectrum: Results From the What Matters Most Survey

    Sep 22, 2025, 16:24 PM
  • The Value of the Health and Well-being Benefits of Healthcare Facilities Outdoor Spaces

    Sep 22, 2025, 16:24 PM
  • Advancing Preference Elicitation Techniques for Rare Diseases and Limited Sample Populations

    Sep 22, 2025, 16:24 PM
  • Integrating Quantitative Patient and Carer Insights into HTA: The Impact of a Patient Organisation Survey on a NICE Appraisal

    Sep 22, 2025, 16:24 PM
  • Exploring Value Creation through Risk-Sharing Agreements in Oncology: Case Studies in Lung Cancer and Hepatocellular Carcinoma

    Sep 22, 2025, 16:24 PM
  • Seeking Patient and Public’s Opinions to Determine Target Differences in Clinical Trials: A Scoping Review of Elicitation Methods

    Sep 22, 2025, 16:24 PM
  • Carbon Footprint Associated With Severe Asthma Care Before and After Benralizumab Initiation: BENEFIT Study

    Sep 22, 2025, 16:24 PM
  • Inter-Tumor Lesions Can Be Discordant—Medical Policies Should Not: Enabling Precision Diagnostics with F18 fluoroestradiol (Cerianna) PET/CT in Estrogen Receptor-Positive Metastatic Breast Cancer

    Sep 22, 2025, 16:24 PM
  • "Tell Me a Story": A Randomized Study Comparing Tabulated and Narrative Presentations of a Discrete Choice Experiment

    Sep 22, 2025, 16:24 PM
  • Associations Between Undernutrition and Healthcare Utilization and Costs in Community-Dwelling Adults: A Longitudinal Observational Study

    Sep 22, 2025, 16:24 PM
  • Incorporating Environmental Impacts Into Budget Impact Models: A Case Study of CAR-T Therapies in France

    Sep 22, 2025, 16:24 PM
  • Predicting Treatment Effect on the Loss of Ability to Rise From Floor in Duchenne Muscular Dystrophy Using Individual Trajectories: An Application of Joint Modeling in FOR-DMD

    Sep 22, 2025, 16:24 PM
  • Approximating Competing Risk Events From Published Kaplan-Meier Curves Using Simultaneity-Based Event Assignment Methods

    Sep 22, 2025, 16:24 PM
  • The Healthcare Improvement Scotland Think Frailty Tool: A Preliminary Psychometric Evaluation

    Sep 22, 2025, 16:24 PM
  • 1
  • 2 (current)
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • »
Quick Links

  • About
  • Media Center
  • Exhibits & Sponsorships
  • Contact Us
Policies & Legal

  • Antitrust Compliance
  • Code of Ethics
  • Diversity Policy
  • Funding Statement
  • Legal Disclaimer
  • Privacy Policy

Subscribe

Join ISPOR


ISPOR–The Professional Society for
Health Economics and Outcomes Research

Copyright © 2018 ISPOR. All rights reserved.

International Society for Pharmacoeconomics and Outcomes Research, Inc

Website Design & Development by Matrix Group